Q2 EPS Estimate for Inovio Pharmaceuticals Cut by Analyst
Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) – Equities researchers at HC Wainwright lowered their Q2 2025 earnings per share estimates for shares of Inovio Pharmaceuticals in a research report issued on Wednesday, May 14th. HC Wainwright analyst R. Selvaraju now forecasts that the biopharmaceutical company will post earnings of ($0.69) per share for the […]
